Chris Cain's most recent trade in Cogent Biosciences Inc was a trade of 44,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cogent Biosciences Inc | Christopher W. Cain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,700 | 44,700 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Christopher W. Cain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 36,700 | 36,700 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Christopher W. Cain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 30,700 | 30,700 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Christopher W. Cain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
Cogent Biosciences Inc | Chris Cain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2020 | 28,661 | 28,661 | - | - | Director Stock Option (Right to Buy) |